Litcius/Paper detail

Murine double minute 2 inhibition alone or with cytarabine in acute myeloid leukemia: Results from an idasanutlin phase 1/1b study⋆

Karen Yee, Cristina Papayannidis, Norbert Vey, Michael Dickinson, Kevin R. Kelly, Sarit Assouline, Margaret Kasner, Karen Seiter, Mark W. Drummond, Sung‐Soo Yoon, Je‐Hwan Lee, Steven Blotner, Lori Jukofsky, William E. Pierceall, Jianguo Zhi, Silke Simon, Brian Higgins, Gwen Nichols, Annabelle Monnet, Susanne Muehlbauer, Marion Ott, Lin-Chi Chen, Giovanni Martinelli

2020Leukemia Research47 citationsDOI

Topics & Concepts

CytarabineMedicineMyeloid leukemiaAdverse effectInternal medicineGastroenterologyRefractory (planetary science)MyeloidLeukemiaAcute leukemiaPharmacologyBiologyAstrobiologyAcute Myeloid Leukemia ResearchAcute Lymphoblastic Leukemia researchDNA Repair Mechanisms
Murine double minute 2 inhibition alone or with cytarabine in acute myeloid leukemia: Results from an idasanutlin phase 1/1b study⋆ | Litcius